Standard BioTools Competitors
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|---|
| AVGO | Broadcom | Outperform |
8
|
$1.40k | Buy/Sell | $1.21k | 11.80% | 11 | $646.61B |
| TMO | Thermo Fisher Scientific | Outperform |
10
|
$595.30 | Buy/Sell | $591.94 | 4.15% | 1 | $227.24B |
| ROG | Roche Holding | Hold |
16
|
CHF237.10 | Buy/Sell | CHF307.83 | 14.93% | 9 | CHF191.28B |
| DHR | Danaher | Outperform |
10
|
$265.80 | Buy/Sell | $260.33 | 2.49% | 4 | $196.87B |
| ABT | Abbott Laboratories | Outperform |
9
|
$104.09 | Buy/Sell | $118.92 | 21.53% | 7 | $181.08B |
| SIE | Siemens | Outperform |
10
|
172.56€ | Buy/Sell | 178.14€ | 13.58% | 11 | 135.26€B |
| BDX | Becton Dickinson and Co | Outperform |
9
|
$236.30 | Buy/Sell | $284.47 | 17.44% | 8 | $68.29B |
| A | Agilent Technologies | Outperform |
10
|
$154.23 | Buy/Sell | $138.82 | -2.09% | 10 | $45.20B |
| ILMN | Illumina | Outperform |
16
|
$111.07 | Buy/Sell | $159.28 | 32.80% | 9 | $17.69B |
| BIM | bioMérieux | Outperform |
18
|
95.90€ | Buy/Sell | 105.55€ | 19.92% | 1 | 11.73€B |
| TECH | Bio-Techne Corp | Buy |
16
|
$83.81 | Buy/Sell | $100.78 | 0.23% | 2 | $12.55B |
| QGEN | QIAGEN N.V. | Outperform |
15
|
$45.69 | Buy/Sell | $0.00 | 9.43% | 3 | $9.67B |
| BIO | Bio-Rad Laboratories Inc | Outperform |
16
|
$293.85 | Buy/Sell | $536.80 | 40.89% | 1 | $7.92B |
| TXG | 10x Genomics | Outperform |
6
|
$25.01 | Buy/Sell | $58.14 | 61.94% | 2 | $3.16B |
| QDEL | Quidel Corp | Hold |
16
|
$42.82 | Buy/Sell | $121.00 | 12.10% | 6 | $2.92B |
| CTKB | Cytek Biosciences | Outperform |
2
|
$6.10 | Buy/Sell | $10.00 | 63.93% | 1 | $813.84M |
| NSTG | NanoString Technologies | - |
7
|
$0.12 | Buy/Sell | $5.02 | -100.00% | 4 | $6.98M |
| NVTA | Invitae | - |
4
|
$0.00 | Buy/Sell | $0.71 | 0.00% | 8 | $3.18M |